BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23824908)

  • 1. Prostate cancer screening: a complicated puzzle, explanation needed.
    Gaster B
    J Gen Intern Med; 2013 Dec; 28(12):1549-50. PubMed ID: 23824908
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations against prostate cancer screening with PSA].
    Marzo-Castillejo M; Nuin-Villanueva MÁ; Vela-Vallespín C
    Aten Primaria; 2012 Jul; 44(7):377-8. PubMed ID: 22520080
    [No Abstract]   [Full Text] [Related]  

  • 4. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
    Borofsky MS; Makarov DV
    Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 7. Reconsidering Prostate Cancer Screening.
    Schmidt C
    J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change?
    Van der Kwast TH; Roobol MJ
    Nat Rev Urol; 2017 Aug; 14(8):457-458. PubMed ID: 28607501
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for prostate cancer.
    Croswell J; Shin YR
    Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
    [No Abstract]   [Full Text] [Related]  

  • 10. Don't test -- don't treat: the new paradigm for the treatment of prostate cancer?
    Albani JM
    Mo Med; 2011; 108(6):409-12. PubMed ID: 22338731
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
    J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: optimization of PSA screening policies: a comparison of the patient and societal perspectives.
    Penson DF
    J Urol; 2013 Feb; 189(2):529-30. PubMed ID: 23312159
    [No Abstract]   [Full Text] [Related]  

  • 13. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 14. Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.
    Shoag J; Halpern JA; Lee DJ; Mittal S; Ballman KV; Barbieri CE; Hu JC
    J Urol; 2016 Oct; 196(4):1047-52. PubMed ID: 27060052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: PSA update--no change yet.
    Phillips R
    Nat Rev Urol; 2014 Sep; 11(9):483. PubMed ID: 25134834
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New PSA guidelines discourage overscreening.
    Peres J
    J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer: modeling the outcomes of prostate cancer screening.
    Loeb S; Carlsson S; Braithwaite RS
    Nat Rev Urol; 2012 Mar; 9(4):183-5. PubMed ID: 22410678
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer risk calculators using ERSPC-derived data underestimate the risk if the WHO IRP 96/670 standard is used in prostate-specific antigen analysis.
    Tormey WP
    Eur Urol; 2015 Sep; 68(3):541-2. PubMed ID: 25819721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.